| Sector |
Agriculture
|
Compare with Sector peers |
| Industry |
Floriculture
|
Compare with Industry peers |
| Website | http://www.indrayani.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 40.15 Cr. | |
| Earnings per share (EPS) | -1.10 | Trailing Twelve Months Ending 2021-06 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2021-06 |
| Industry PE | - | Trailing Twelve Months Ending 2021-06 |
| Book Value / Share | 7.57 | Trailing Twelve Months Ending 2021-06 |
| Price to Book Value | 1.55 | Calculated using Price: 11.73 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 3.42 Cr. | 34,227,192 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds. Indrayani Biotech produces cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company has also started marketing and distribution and extensive field demonstrations of hybrid vegetable seeds manufactured by HOECHST India. Technical agreements have been signed with Floral Max, Malaysia for rose cultivation and with B. L. McKenzie and Associates, New Zealand for tissue culture. The planting material for strawberries has been acquired from the US. Indrayani Biotech has signed a test agreement with the technology transfer offer of the University of California to obtain certified planting material from nurseries in California. Indrayani Biotech started exporting flowers to Holland and Dubai in 1994-1995. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-1996, the company incurred losses due to insufficient water supply, labor problems and sub-standard infrastructure. To overcome the above problems, the company is considering shifting its green houses to alternate locations. The company has installed five Greenhouses and plantation in these greenhouses is complete. A pilot tissue culture laboratory is also completed and the protocol to be used in manufacture of tissue culture plantlets is being perfected. The company’s registered office and factory are located at Pune, India. |
||
Company Profile
The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds.
Indrayani Biotech produces cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company has also started marketing and distribution and extensive field demonstrations of hybrid vegetable seeds manufactured by HOECHST India. Technical agreements have been signed with Floral Max, Malaysia for rose cultivation and with B. L. McKenzie and Associates, New Zealand for tissue culture. The planting material for strawberries has been acquired from the US. Indrayani Biotech has signed a test agreement with the technology transfer offer of the University of California to obtain certified planting material from nurseries in California.
Indrayani Biotech started exporting flowers to Holland and Dubai in 1994-1995. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-1996, the company incurred losses due to insufficient water supply, labor problems and sub-standard infrastructure. To overcome the above problems, the company is considering shifting its green houses to alternate locations.
The company has installed five Greenhouses and plantation in these greenhouses is complete. A pilot tissue culture laboratory is also completed and the protocol to be used in manufacture of tissue culture plantlets is being perfected.
The company’s registered office and factory are located at Pune, India.
| 1 Day |
|
+4.92% |
| 1 Week |
|
+21.30% |
| 1 Month |
|
+13.55% |
| 3 Month |
|
+88.59% |
| 6 Month |
|
+66.86% |
| 1 Year |
|
+39.98% |
| 2 Year |
|
+113.27% |
| 5 Year |
|
+76.39% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | -2.38 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | ||||
| Return on Capital Employed (%) | -2.38 | -0.17 | -1.98 | -2.88 | -3.67 | -5.87 | ||||
| Return on Assets (%) | -2.32 | -0.17 | -1.98 | -2.88 | -3.66 | -5.88 | -1,964.39 | -670.67 | -181.70 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 3 | 3 | 3 | 3 | 3 | 0 | -1 | -1 | -1 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||
| Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Minority Int. | ||||||||||
| Equity & Liab. | 4 | 4 | 4 | 4 | 4 | 0 | 0 | 0 | ||
| Non Curr. Assets | 4 | 4 | 4 | 4 | 4 | |||||
| Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 4 | 4 | 4 | 4 | 4 | 0 | 0 | 0 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 1 | |||||||||
| Other Income | 0 | |||||||||
| Total Income | 0 | 1 | ||||||||
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | |||||||||
| Depreciation | 0 | |||||||||
| Taxation | ||||||||||
| Exceptional Items | 0 | |||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash Fr. Inv. | 0 | |||||||||
| Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 |
|
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021 Indrayani Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
|
Fri, 16 Jul 2021
Outcome For The Board Meeting Held On 16Th July 2021 Please find the attached Board Outcome held on 16th July 2021 |
|
Wed, 07 Jul 2021
Closure of Trading Window Closure of Trading Window for dealing in securities of the Bank in terms of SEBI (Prohibition of Insider Trading) Regulations 2015 |
| Mon, 26 Jul 2021 |
Stock Outperforming Benchmark Index in both 1 Week and 3 Month
|
Stock Outperforming Sectoral Index in both 1 Week and 3 Month
|
Strongly Outperforming Benchmark Index
|
Increasing Relative Strength - Benchmark index
|
Strongly Outperforming Sectoral Index
|
Equities
M.F.
Sectors